Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye

Study Identifier
GMA-EAME-EYE-0368
CT.gov Identifier
NCT02951975
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Other
Sign up for trial alerts

Study Details

Medical Condition
  • Uveitis
    • Study Drug
  • dexamethasone intravitreal implant
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    -Patient with non-infectious uveitis affecting the posterior segment of the eye.
    Exclusion Criteria:
    -Patient not residing in metropolitan France.

    Protocol Summary

    This observational study will evaluate the safety, efficacy, characteristics of patients, characteristics of physicians and quality of life in patients who are prescribed OZURDEX® as treatment for non-infectious uveitis of the posterior segment of the eye in France.

    Study Locations

    Location
    Status
    Location
    CHU Amiens
    Amiens, France, 80000
    Status
    Not applicable
    Location
    IOP Institut Ophtalmologique de Picardie
    Amiens, France, 80000
    Status
    Not applicable
    Location
    Centre Rétine Gallien
    Bordeaux, France, 33000
    Status
    Not applicable
    Location
    Hopital Pellegrin
    Bordeaux, France, 33076
    Status
    Not applicable
    Location
    CHI de Créteil
    Créteil, France, 94000
    Status
    Not applicable
    Location
    CHU Dijon
    Dijon, France, 21079
    Status
    Not applicable
    Showing {first} - {last} of {total} Results